News

News

Oculogica Hosts Webinar: Long COVID and the Effects on the Brain

This webinar featured Dr. Avindra Nath, Clinical Director at Translational Neuroscience Center at the National Institute of Neurological Disorders and Stroke (NIH), Dr. Uzma Samadani, …

News

Oculogica’s eye-tracking concussion detector adopted by Minneapolis Clinic of Neurology

Minneapolis Clinic of Neurology, one of the largest neurology clinics in the nation, has recently made the decision to offer Oculogica Inc.’s EyeBox to patients who may have a concussion.

News

CEO Dr. Rosina Samadani joins Christopher Reed in a Webinar to Discuss the Headstrong Concussion Insurance Program

Please join us on August 10th at 12pm CT for a 30 minute webinar to learn about the HeadStrong Concussion Insurance program for high school students, a $0 deductible and no co-pay plan for students in AZ, CA (self-insured schools), MT, MI, MN, WY, WI, and IA, and the EyeBOX, the first and only FDA cleared objective concussion diagnostic device.

News

Oculogica CEO, Dr. Rosina Samadani, and Founder, Dr. Uzma Samadani, Discuss the EyeBOX on the Talk Polymath Podcast

Watch Oculogica CEO, Dr. Rosina Samadani’s, and founder, Dr. Uzma Samadani’s discussion with the Talk Polymath podcast about the EyeBOX and how eye movement can be used to diagnose and treat concussions.

News

CEOX: CEO Interview Series – Rosina Samadani, CEO of Oculogica

Oculogica CEO, Dr. Rosina Samadani, speaks with CEOX for their CEO Interview Series.

News

Oculogica’s New Patent Opens Potential for a CTE Test for Live Subjects

Oculogica receives ground-breaking patent to assess CTE via its eye-tracking technology

News

Oculogica Adds to IP Portfolio with Patent for Assessment of Impairment Due to Cannabis

Oculogica’s patent enables expansion of its eye-tracking based technology to fulfill an unmet need in cannabis impairment detection

News

Oculogica Receives Department of Defense Grant to Develop Wearable Concussion Diagnostic with Pre-eminent Partners

Keller Army Hospital at West Point, Children’s Hospital of Philadelphia, University of Wisconsin-Green Bay and AdHawk Microsystems will work with Oculogica to develop the wearable diagnostic

News

Australia’s TGA Grants Approval to First Objective Concussion Diagnostic

Oculogica, a medical device company and leader in concussion diagnosis and categorization, announced today the Therapeutic Goods Administration (TGA) of Australia granted approval to its EyeBOX technology. The test is for both pediatrics and adults. The technology is also patent protected in Australia.

Scroll to Top